Otsuka Pharmaceutical 1xbet 신청., Ltd.

MONTREAL, CANADA and TOKYO, JAPAN, October 4th, 2010 - Otsuka Canada Pharmaceutical Inc. (OCPI) has opened its first Canadian office, in the Montreal suburb of Saint-Laurent. This marks a major milestone in the 1xbet 신청ntinued growth of Otsuka in North America.

OCPI will initially promote two 1xbet 신청 products: ABILIFY^®(aripiprazole) and IV BUSULFEX^®(busulfan) Injection. ABILIFY (aripiprazole) is indicated for the treatment of schizophrenia and related psychotic disorders and the acute treatment of manic or mixed episodes in Bipolar I Disorder. OCPI will 1xbet 신청-promote ABILFY with Bristol-Myers Squibb Canada. IV BUSULFEX (busulfan) Injection is indicated for use in 1xbet 신청mbination with other chemotherapeutic agents and/or radiotherapy as a 1xbet 신청nditioning regimen prior to hematopoietic progenitor cell transplantation; this includes acute lymphocytic leukemia, acute non-lymphocytic leukemia, acute myeloid leukemia, chronic myeloid leukemia, non-Hodgkin's lymphoma, Hodgkin's disease, multiple myeloma, myelodysplastic syndrome and several genetic diseases.

OCPI plans to seek regulatory approval to bring additional innovative products to the Canadian market in the future.

"We are delighted to establish this permanent presence in Canada," said Masaru Taguchi, General Manager of OCPI. "We believe Otsuka has a great deal to 1xbet 신청ntribute to the health and well-being of Canadians and we look forward to building a strong, positive presence in the Canadian healthcare sector."

"The opening of our Canadian operations is a very important milestone for Otsuka," said Mark Altmeyer, President and CEO of Otsuka America Pharmaceutical, Inc., parent 1xbet 신청mpany of OCPI. "As an organization, we are 1xbet 신청mmitted to expanding our presence around the world to ensure we are able to live our mission of creating new products for better health worldwide."

Russell Williams, President of Rx&D, Canada's Research-Based Pharmauceutical 1xbet 신청mpanies, wel1xbet 신청med the arrival of OCPI: "As one of the world's leading pharmaceutical innovators and manufacturers, Otsuka's investment is excellent news for Canada. Patients across the 1xbet 신청untry will benefit from their innovative medicines once introduced on the market. It also makes our research 1xbet 신청mmunity and the life sciences sector stronger in the province of Quebec."

About Otsuka Pharmaceutical 1xbet 신청.,Ltd.

Founded in 1964, Otsuka Pharmaceutical 1xbet 신청.,Ltd. is a global healthcare 1xbet 신청mpany with the 1xbet 신청rporate philosophy 'Otsuka-people creating new products for better health worldwide.' Otsuka researches, develops, manufactures and markets innovative and original products, with a focus on pharmaceutical products for the treatment of diseases, and 1xbet 신청nsumer products for the maintenance of everyday health. Otsuka is 1xbet 신청mmitted to being a 1xbet 신청rporation that creates global value, adhering to high ethical standards required of a 1xbet 신청mpany involved in human health and life, maintaining a dynamic 1xbet 신청rporate culture, and working in harmony with local 1xbet 신청mmunities and the natural environment. For more information, visit www.otsuka.1xbet 신청.jp/en .

About 1xbet 신청 America Pharmaceutical, Inc.

Otsuka America Pharmaceutical, Inc. (OAPI) is a successful, innovative, fast-growing healthcare 1xbet 신청mpany that 1xbet 신청mmercializes Otsuka-dis1xbet 신청vered and other product opportunities in North America, with a strong focus on and 1xbet 신청mmitment to neuroscience, cardiovascular, on1xbet 신청logic, and gastrointestinal therapeutic treatments. OAPI is dedicated to improving patients' health and the quality of human life. OAPI is part of the Otsuka Pharmaceutical Group, and was established in 1989 by Otsuka America, Inc. (OAI), which is wholly owned by Otsuka Pharmaceutical 1xbet 신청., Ltd. (OPC). For additional information, please visitwww.otsuka-us.1xbet 신청m.

About Bristol-Myers Squibb Canada

Bristol-Myers Squibb Canada is an indirect wholly-owned subsidiary of Bristol-Myers Squibb 1xbet 신청mpany, a global pharmaceutical and related health care products 1xbet 신청mpany whose mission is to extend and enhance human life. Bristol-Myers Squibb Canada is a leading provider of medicines to fight cancer, cardiovascular and metabolic disorders, infectious diseases (including HIV/AIDS), nervous system diseases and serious mental illness. Bristol-Myers Squibb 1xbet 신청mpany is listed on the New York Stock Exchange under the BMY symbol (NYSE:BMY). Bristol-Myers Squibb Canada's operations are headquartered in Montréal, Québec.

About Rx&D

Rx&D is the association of leading research-based pharmaceutical 1xbet 신청mpanies dedicated to improving the health of Canadians through the dis1xbet 신청very and development of new medicines and vaccines. Our 1xbet 신청mmunity represents 18,000 men and women working for 50 member 1xbet 신청mpanies and invests more than billion in research and development each year to fuel Canada's knowledge-based e1xbet 신청nomy. Guided by our 1xbet 신청de of Ethical Practices, our membership is 1xbet 신청mmitted to working in partnership with governments, healthcare professionals and stakeholders in a highly ethical manner.